Geneos Wealth Management Inc. Macrogenics Inc Call Options Transaction History
Geneos Wealth Management Inc.
- $2.77 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MGNX
# of Institutions
130Shares Held
55.7MCall Options Held
28.3KPut Options Held
197K-
Bellevue Group Ag Kuesnacht, V89.93MShares$16.9 Million0.64% of portfolio
-
Armistice Capital, LLC New York, NY6.28MShares$10.7 Million0.29% of portfolio
-
Black Rock Inc. New York, NY5.4MShares$9.18 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.32MShares$7.34 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.49MShares$5.93 Million0.06% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $104M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...